Principal Biostatistician H-1B salary at Novartis Pharmaceuticals — 102 certified filings (FY2017–FY2026)
- 11
- Filings · FY2025
- $143k
- Median base · FY2025
- $143k–$143k
- Middle 50% · FY2025
- −13%
- vs market median · all years
Novartis Pharmaceuticals filed 11 certified H-1B LCAs for Principal Biostatistician in FY2025, with a median base salary of $143k and the middle 50% of offers between $143k and $143k. Across all years its $113k median is 13% below the $130k market median for Principal Biostatistician. It has filed 102 Principal Biostatistician LCAs since FY2017, most often in East Hanover, NJ.
How much does Novartis Pharmaceuticals pay a Principal Biostatistician?
Certified base salary for Principal Biostatistician at Novartis Pharmaceuticals by fiscal year: each box is the p25–p75 range, the heavy line the median, the whiskers reach p10–p90. $143k median in FY2025. Base pay only — hover a year for its figures.
Does Novartis Pharmaceuticals pay Principal Biostatisticians above the market?
Novartis Pharmaceuticals's all-years median against every employer's certified Principal Biostatistician LCAs — 13% below the market. Same cleaned DOL title, same base-salary definition, so the two rows compare like for like.
| Base salary for this title | Filings | Median |
|---|---|---|
| Novartis Pharmaceuticals | 102 | $113k |
| All employers · Principal Biostatistician | 299 | $130k |
How has Novartis Pharmaceuticals's Principal Biostatistician hiring changed by year?
6 certified Principal Biostatistician filings in FY2017 → 10 in FY2026. The change column is each year against the one before.
| Fiscal year | Filings | vs prior FY | Median base |
|---|---|---|---|
| FY2026 | 10 | −9% | $113k |
| FY2025 | 11 | 0% | $143k |
| FY2024 | 11 | −31% | $136k |
| FY2023 | 16 | +45% | $101k |
| FY2022 | 11 | 0% | $105k |
| FY2021 | 11 | −21% | $92k |
| FY2020 | 14 | +180% | $90k |
| FY2019 | 5 | −29% | $119k |
| FY2018 | 7 | +17% | $123k |
| FY2017 | 6 | — | $117k |
Which wage levels does Novartis Pharmaceuticals file for Principal Biostatistician?
DOL prevailing-wage levels I–IV approximate experience tiers (I = entry, IV = fully competent). 46% of Novartis Pharmaceuticals's Principal Biostatistician filings sit at Level III–IV. Higher levels earn more entries in the wage-weighted H-1B lottery.
Share of 102 Principal Biostatistician filings with a wage level · all years
- Level I6.9%7
- Level II47.1%48
- Level III36.3%37
- Level IV9.8%10
Where does Novartis Pharmaceuticals hire H-1B Principal Biostatisticians?
Worksite states and cities on the certified filings for this title, all years, with the median base salary at each.
| State | Filings | Median base |
|---|---|---|
| New Jersey | 95 | $113k |
| Massachusetts | 6 | $101k |
| Texas | 1 | $109k |
| City | Filings | Median base |
|---|---|---|
| East Hanover, NJ | 94 | $113k |
| Cambridge, MA | 6 | $101k |
| Forth Worth, TX | 1 | $109k |
| Princeton, NJ | 1 | $134k |
Also filed as
Novartis Pharmaceuticals's other sponsored titles, and the employers that file the most Principal Biostatistician LCAs. All years.
Other titles at Novartis Pharmaceuticals
| Job title | Filings | Median base |
|---|---|---|
| Senior Principal Biostatistician | 42 | $119k |
Top Principal Biostatistician sponsors
| Employer | Filings | Median base |
|---|---|---|
| Biogen | 26 | $119k |
| Regeneron Pharmaceuticals | 25 | $145k |
| Vertex Pharmaceuticals | 22 | $145k |
| Incyte | 17 | $125k |
| Novartis Institutes for Biomedical Research | 14 | $101k |
| Parexel International | 9 | $162k |
| Edwards Lifesciences | 8 | $136k |
| Bristol- Myers Squibb | 6 | $129k |
| Sandoz | 5 | $137k |
Common questions about Principal Biostatistician H-1B pay at Novartis Pharmaceuticals
- How much does Novartis Pharmaceuticals pay a Principal Biostatistician on an H-1B?
- Novartis Pharmaceuticals's median certified H-1B base salary for Principal Biostatistician is $143k in FY2025, from 11 filings; the middle 50% of offers fall between $143k and $143k. Across all years the median is $113k.
- How many Principal Biostatistician H-1B LCAs has Novartis Pharmaceuticals filed?
- Novartis Pharmaceuticals has 102 certified H-1B Labor Condition Applications for Principal Biostatistician on record (FY2017–FY2026), 10 of them in FY2026. That is 11% of its 897 certified filings across all titles.
- Does Novartis Pharmaceuticals pay Principal Biostatisticians above the market?
- Novartis Pharmaceuticals's all-years median of $113k is 13% below the $130k median for Principal Biostatistician across all H-1B employers (299 certified filings).
- Where does Novartis Pharmaceuticals hire H-1B Principal Biostatisticians?
- Novartis Pharmaceuticals's Principal Biostatistician LCAs name worksites mostly in New Jersey, Massachusetts, Texas; the top cities are East Hanover, NJ, Cambridge, MA, Forth Worth, TX.
- Does a certified LCA mean an H-1B visa was approved?
- No. A Labor Condition Application (LCA) is the Department of Labor attestation an employer must have certified before filing an H-1B petition with USCIS. It records the job, worksite and offered wage, but not whether the petition was filed, selected in the lottery, or approved. Filing counts measure intent to sponsor, not headcount.
- What salary do these figures show?
- The base annual wage offered on the certified LCA, converted to a yearly amount. Bonus, equity, overtime and benefits are not included, so total compensation is typically higher. Figures are medians and percentiles over certified filings; wages above $5,000,000 a year are excluded as data-entry errors.
- What do prevailing-wage levels I–IV mean?
- The Department of Labor assigns each LCA an OES wage level from I (entry) to IV (fully competent) for the occupation and area. Under the FY2027 wage-weighted H-1B lottery rule, a higher level earns more selection entries, so an employer's level mix is a proxy for how senior its sponsored roles are.
Keep exploring
Calculate your H-1B lottery odds →orCheck out the insights →
Source: U.S. Department of Labor, Office of Foreign Labor Certification — certified LCA disclosure data through June 2026 (FY2017–FY2026). An LCA is not an approved visa; pay figures are base salary and exclude bonus and equity. Methodology →